Zobrazeno 1 - 10
of 11
pro vyhledávání: '"Gizeh Perez-Tenorio"'
Autor:
Giulia Falivelli, Erika Mathes Lisabeth, Elena Rubio de la Torre, Gizeh Perez-Tenorio, Giovanna Tosato, Ombretta Salvucci, Elena B Pasquale
Publikováno v:
PLoS ONE, Vol 8, Iss 11, p e81445 (2013)
The Eph receptor tyrosine kinases mediate juxtacrine signals by interacting "in trans" with ligands anchored to the surface of neighboring cells via a GPI-anchor (ephrin-As) or a transmembrane segment (ephrin-Bs), which leads to receptor clustering a
Externí odkaz:
https://doaj.org/article/2f20dbc2f88a477bbf88416230d1e9d0
Autor:
Annelie, Johansson, Huma, Dar, Laura J, van 't Veer, Nicholas P, Tobin, Gizeh, Perez-Tenorio, Anna, Nordenskjöld, Ulla, Johansson, Johan, Hartman, Lambert, Skoog, Christina, Yau, Christopher C, Benz, Laura J, Esserman, Olle, Stål, Bo, Nordenskjöld, Tommy, Fornander, Linda S, Lindström
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 40(35)
To assess the long-term (20-year) endocrine therapy benefit in premenopausal patients with breast cancer.Secondary analysis of the Stockholm trial (STO-5, 1990-1997) randomly assigning 924 premenopausal patients to 2 years of goserelin (3.6 mg subcut
Autor:
Oscar Danielsson, Huma Dar, Gizeh Perez-Tenorio, Anna Nordenskjöld, Christina Yau, Christopher C. Benz, Laura J. Esserman, Bo Nordenskjöld, Olle Stål, Tommy Fornander, Annelie Johansson, Linda S. Lindström
Publikováno v:
Cancer Research. 83:P3-05
Background: Women with estrogen receptor (ER)-positive disease have a long-term risk of distant recurrence. The poor survival of premenopausal women diagnosed with breast cancer combined with the otherwise long life expectancy makes it especially imp
Autor:
Josefine Sandström, Jens Bomanson, Gizeh Pérez-Tenorio, Carolin Jönsson, Bo Nordenskjöld, Tommy Fornander, Linda S. Lindström, Olle Stål
Publikováno v:
npj Breast Cancer, Vol 10, Iss 1, Pp 1-9 (2024)
Abstract GATA binding protein 3 (GATA3) is essential for normal development of the mammary gland and associated with ER-positive breast cancer. Loss of GATA3 has been associated with epithelial-mesenchymal transition (EMT) in experimental studies. We
Externí odkaz:
https://doaj.org/article/5489900ba9c54810a4ba6d86094baf2b
Autor:
Annelie Johansson, Huma Dar, Anna Nordenskjöld, Gizeh Perez-Tenorio, Christina Yau, Christopher C. Benz, Laura J. Esserman, Laura Van’t Veer, Bo Nordenskjöld, Olle Stål, Tommy Fornander, Linda S. Lindström
Publikováno v:
Cancer Research. 83:P2-03
Background: Tamoxifen is a standard endocrine therapy for both pre- and postmenopausal ER-positive breast cancer patients. Patients with ER-positive disease have a long-term risk of distant recurrence, thus, long-term follow-up studies are essential
Autor:
Huma Dar, Annelie Johansson, Anna Nordenskjöld, Gizeh Perez-Tenorio, Christina Yau, Christopher C. Benz, Laura J. Esserman, Bo Nordenskjöld, Olle Stål, Tommy Fornander, Linda S. Lindström
Publikováno v:
Cancer Research. 83:P2-03
Background: The risk for patients with estrogen receptor (ER)-positive breast cancer remains stable decades after primary diagnosis, with a large proportion of distant metastatic events occurring late. Thus, long-term follow-up studies are essential
Autor:
Jenny, Pousette, Annelie, Johansson, Carolin, Jönsson, Tommy, Fornander, Linda S, Lindström, Hans, Olsson, Gizeh, Perez-Tenorio
Publikováno v:
Cancers. 14(19)
The clinical impact of tumor-infiltrating lymphocytes (TILs) is less known for breast cancer patients with the estrogen receptor-positive (ER+)/human epidermal growth factor receptor-negative (HER-) subtype. Here, we explored the prognostic and predi
Autor:
Annelie Johansson, Nancy Y. Yu, Adina Iftimi, Nicholas P. Tobin, Laura 't Veer, Bo Nordenskjöld, Christopher C. Benz, Tommy Fornander, Gizeh Perez‐Tenorio, Olle Stål, Laura J. Esserman, Christina Yau, Linda S. Lindström
Publikováno v:
International journal of cancer. 150(12)
The metastatic potential of estrogen receptor (ER)-positive breast cancers is heterogeneous and distant recurrences occur months to decades after primary diagnosis. We have previously shown that patients with tumors classified as ultralow risk by the
Autor:
Carolin Jönsson, Zeinab Alkashaf, Josefine Sandström, Annelie Johansson, Tommy Fornander, Linda S. Lindström, Gizeh Perez Tenorio
Publikováno v:
Cancer Research. 83:B027-B027
The PIK3CA gene, encoding the p110α catalytic subunit of PI 3-kinase (PI3K), is mutated in more than 30% of breast cancers. Most mutations concentrate to the hotspots E542K and E545K and H1047R and are associated with hyperactivation of the phosphat
Autor:
Huma, Dar, Annelie, Johansson, Anna, Nordenskjöld, Adina, Iftimi, Christina, Yau, Gizeh, Perez-Tenorio, Christopher, Benz, Bo, Nordenskjöld, Olle, Stål, Laura J, Esserman, Tommy, Fornander, Linda S, Lindström
Publikováno v:
JAMA network open. 4(6)
Clinically used breast cancer markers, such as tumor size, tumor grade, progesterone receptor (PR) status, and Ki-67 status, are known to be associated with short-term survival, but the association of these markers with long-term (25-year) survival i